- Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor
-
Moon DR, Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2363766
- Korean J Ophthalmol.
- 2015 Aug;29(4):226-232.
- doi: 10.3341/kjo.2015.29.4.226
PURPOSE: To report the results of switching treatment to vascular endothelial growth factor (VEGF) Trap-Eye (aflibercept) in neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) refractory to anti-VEGF... -
- CITED
-
- Close
- SHARE
-
- Close
